Singapore in talks with Pfizer in quest for multiple vaccine sources

Singapore

SINGAPORE'S strategy is not to depend on any single source for Covid-19 vaccines, the authorities said on Tuesday. This is even as the government is in discussion with major pharmaceutical companies including Pfizer, whose experimental vaccine was reported to be 90 per cent effective.

At a virtual press conference, Kenneth Mak, director of medical services at Singapore's Ministry of Health, said: "Our current thinking is not to depend on any single vaccine candidate, but it's very likely that we will develop a portfolio of different vaccines that may therefore be relevant and appropriate for different segments of the population."